The Challenges of Psilocybin Legal Licensing and Compliance
Join us for an exclusive webinar focused on psilocybin licensing and compliance with expert speaker Ryan Pincura, Director of Regulatory Affairs at Tendrel Group.
The Future of Consumer Neuroscience in Food Research
In this webinar, our expert speaker, Dr. Michelle Niedziela, VP of Research and Innovation at HCD Research will discuss how to better evaluate and implement research methodologies in practice as well as discuss best practices and the future of the field.
Novel Chemical Entities in Psychedelics: Risks and Rewards for Investors
Join us for an exclusive panel discussion focused on research and development relating to novel chemical entities in the psychedelics industry and some of the viable business models that are emerging in this field.
Looking to the Future of Cell and Gene Therapies
This Technology Networks event features exclusive talks focused on the most recent and innovative developments in the world of cell and gene therapies. Our expert speakers will highlight the opportunities cell and gene therapies provide for the treatment of disease and injury, including how cell therapies are providing novel solutions for rare diseases such as Duchenne muscular dystrophy.
Preventing Ex Vivo Activational Confounds in Single-Cell Neuroscience Studies
A long-standing concern for neuroscientists studying specific cell types in vivo is whether cell isolation from CNS tissue induces ex vivo activational artifacts that confound experimental interpretations.
Alzheimer's Disease Pathogenesis: Emerging Role of Microglia
Alzheimer’s disease is the most common form of neurodegenerative disease, estimated to contribute to 60–70% of all cases of dementia worldwide. Increasing evidence suggests that neuroinflammation, primarily mediated by microglia, contributes to the onset and progression of Alzheimer’s disease.